Effect of common KCNE1 and SCN5A ion channel gene variants on T-wave alternans, a marker of cardiac repolarization, during clinical exercise stress test: the Finnish Cardiovascular Study

Translational Research

Volumn 152, Issue 2, 2008, Pages 49-58

  Koskela, Jenni ^a   Kähönen, Mika ^a   Fan, Meng ^a   Nieminen, Tuomo ^a   Lehtinen, Rami ^a   Viik, Jari ^a   Nikus, Kjell ^a   Niemelä, Kari ^a   Kööbi, Tiit ^a   Turjanmaa, Väinö ^a   Pörsti, Ilkka ^a   Lehtimäki, Terho ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ION CHANNEL; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL SCN5A; VOLTAGE GATED POTASSIUM CHANNEL;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ELECTROCARDIOGRAM; EXERCISE TEST; FEMALE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEART REPOLARIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; QT INTERVAL; T WAVE AMPLITUDE;

EID: 48149095809     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2008.06.003     Document Type: Article

References (53)

1. Haghjoo M., Arya A., and Sadr-Ameli M.A. Microvolt T-wave alternans: a review of techniques, interpretation, utility, clinical studies, and future perspectives. Int J Cardiol 109 (2006) 293-306
2. Narayan S.M. T-wave alternans and the susceptibility to ventricular arrhythmias. J Am Coll Cardiol 47 (2006) 269-281
3. Moss A.J., Schwartz P.J., Crampton R.S., et al. The long QT syndrome. Prospective longitudinal study of 328 families. Circulation 84 (1991) 1136-1144
4. Chiang C.E., and Roden D.M. The long QT syndromes: genetic basis and clinical implications. J Am Coll Cardiol 36 (2000) 1-12
5. Roden D.M., Lazzara R., Rosen M., Schwartz P.J., Towbin J., Vincent G.M., and The SADS Foundation Task Force on LQTS. Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. Circulation 94 (1996) 1996-2012
6. Kunavarapu C., and Bloomfield D.M. Role of noninvasive studies in risk stratification for sudden cardiac death. Clin Cardiol 27 (2004) 192-197
7. Nieminen T., Lehtimaki T., Viik J., et al. T-wave alternans predicts mortality in a population undergoing a clinically indicated exercise test. Eur Heart J 28 (2007) 2332-2337
8. Ikeda T., Sakata T., Takami M., et al. Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction. A prospective study. J Am Coll Cardiol 35 (2000) 722-730
9. Hohnloser S.H., Klingenheben T., Li Y.G., Zabel M., Peetermans J., and Cohen R.J. T wave alternans as a predictor of recurrent ventricular tachyarrhythmias in ICD recipients: prospective comparison with conventional risk markers. J Cardiovasc Electrophysiol 9 (1998) 1258-1268
10. Bloomfield D.M., Steinman R.C., Namerow P.B., et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation 110 (2004) 1885-1889
11. Klingenheben T., Zabel M., D'Agostino R.B., Cohen R.J., and Hohnloser S.H. Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure. Lancet 356 (2000) 651-652
12. Hohnloser S.H., Klingenheben T., Bloomfield D., Dabbous O., and Cohen R.J. Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study. J Am Coll Cardiol 41 (2003) 2220-2224
13. Platt S.B., Vijgen J.M., Albrecht P., Van Hare G.F., Carlson M.D., and Rosenbaum D.S. Occult T wave alternans in long QT syndrome. J Cardiovasc Electrophysiol 7 (1996) 144-148
14. Momiyama Y., Hartikainen J., Nagayoshi H., et al. Exercise-induced T-wave alternans as a marker of high risk in patients with hypertrophic cardiomyopathy. Jpn Circ J 61 (1997) 650-656
15. Harada M., Shimizu A., Murata M., et al. Relation between microvolt-level T-wave alternans and cardiac sympathetic nervous system abnormality using iodine-123 metaiodobenzylguanidine imaging in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 92 (2003) 998-1001
16. Aydin A., Bahring S., Dahm S., et al. Single nucleotide polymorphism map of five long-QT genes. J Mol Med 83 (2005) 159-165
17. Pfeufer A., Jalilzadeh S., Perz S., et al. Common variants in myocardial ion channel genes modify the QT interval in the general population: results from the KORA study. Circ Res 96 (2005) 693-701
18. Gouas L., Nicaud V., Berthet M., et al. Association of KCNQ1, KCNE1, KCNH2 and SCN5A polymorphisms with QTc interval length in a healthy population. Eur J Hum Genet 13 (2005) 1213-1222
19. Gouas L., Nicaud V., Chaouch S., et al. Confirmation of associations between ion channel gene SNPs and QTc interval duration in healthy subjects. Eur J Hum Genet 15 (2007) 974-979
20. Tristani-Firouzi M., Chen J., Mitcheson J.S., and Sanguinetti M.C. Molecular biology of K(+) channels and their role in cardiac arrhythmias. Am J Med 110 (2001) 50-59
21. Sanguinetti M.C., Curran M.E., Zou A., et al. Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature 384 (1996) 80-83
22. Duggal P., Vesely M.R., Wattanasirichaigoon D., Villafane J., Kaushik V., and Beggs A.H. Mutation of the gene for IsK associated with both Jervell and Lange-Nielsen and Romano-Ward forms of Long-QT syndrome. Circulation 97 (1998) 142-146
23. Splawski I., Tristani-Firouzi M., Lehmann M.H., Sanguinetti M.C., and Keating M.T. Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat Genet 17 (1997) 338-340
24. Friedlander Y., Vatta M., Sotoodehnia N., et al. Possible association of the human KCNE1 (minK) gene and QT interval in healthy subjects: evidence from association and linkage analyses in Israeli families. Ann Hum Genet 69 (2005) 645-656
25. Lai L.P., Deng C.L., Moss A.J., Kass R.S., and Liang C.S. Polymorphism of the gene encoding a human minimal potassium ion channel (minK). Gene 151 (1994) 339-340
26. Wang Q., Shen J., Splawski I., et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 80 (1995) 805-811
27. Viswanathan P.C., Benson D.W., and Balser J.R. A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation. J Clin Invest 111 (2003) 341-346
28. Koskela J., Laiho J., Kähönen M., et al. Potassium channel KCNH2 K897T polymorphism and cardiac repolarization during exercise test: the Finnish Cardiovascular Study. Scand J Clin Lab Invest 68 (2008) 31-38
29. Nieminen T., Lehtinen R., Viik J., et al. The Finnish Cardiovascular Study (FINCAVAS): characterising patients with high risk of cardiovascular morbidity and mortality. BMC Cardiovasc Disord 6 (2006) 9
30. Mason R.E., and Likar I. A new system of multiple-lead exercise electrocardiography. Am Heart J 71 (1966) 196-205
31. Nearing B.D., and Verrier R.L. Modified moving average analysis of T-wave alternans to predict ventricular fibrillation with high accuracy. J Appl Physiol 92 (2002) 541-549
32. Livak K.J. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet Anal 14 (1999) 143-149
33. Rautaharju P.M., Zhou S.H., Wong S., et al. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol 8 (1992) 690-695
34. Priori S.G., Schwartz P.J., Napolitano C., et al. Risk stratification in the long-QT syndrome. N Engl J Med 348 (2003) 1866-1874
35. Nearing B.D., Huang A.H., and Verrier R.L. Dynamic tracking of cardiac vulnerability by complex demodulation of the T wave. Science 252 (1991) 437-440
36. Moss A.J., Zareba W., Hall W.J., et al. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation 101 (2000) 616-623
37. Conrath C.E., Wilde A.A., Jongbloed R.J., et al. Gender differences in the long QT syndrome: effects of beta-adrenoceptor blockade. Cardiovasc Res 53 (2002) 770-776
38. Sokolow M., and Lyon T.P. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 37 (1949) 161-186
39. Ding K., Zhou K., He F., and Shen Y. LDA-a java-based linkage disequilibrium analyzer. Bioinformatics 19 (2003) 2147-2148
40. Stephens M., and Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73 (2003) 1162-1169
41. Akyol M., Jalilzadeh S., Sinner M.F., et al. The common non-synonymous variant G38S of the KCNE1-(minK)-gene is not associated to QT interval in Central European Caucasians: results from the KORA study. Eur Heart J 28 (2007) 305-309
42. Malik M., Farbom P., Batchvarov V., Hnatkova K., and Camm A.J. Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval. Heart 87 (2002) 220-228
43. Busjahn A., Knoblauch H., Faulhaber H.D., et al. QT interval is linked to 2 long-QT syndrome loci in normal subjects. Circulation 99 (1999) 3161-3164
44. Newton-Cheh C., Larson M.G., Corey D.C., et al. QT interval is a heritable quantitative trait with evidence of linkage to chromosome 3 in a genome-wide linkage analysis: the Framingham Heart Study. Heart Rhythm 2 (2005) 277-284
45. Splawski I., Timothy K.W., Tateyama M., et al. Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science 297 (2002) 1333-1336
46. Shimizu W., and Antzelevitch C. Cellular and ionic basis for T-wave alternans under long-QT conditions. Circulation 99 (1999) 1499-1507
47. Livshitz L.M., and Rudy Y. Regulation of Ca2+ and electrical alternans in cardiac myocytes: role of CAMKII and repolarizing currents. Am J Physiol Heart Circ Physiol 292 (2007) H2854-H2866
48. Thomas G., Killeen M.J., Gurung I.S., et al. Mechanisms of ventricular arrhythmogenesis in mice following targeted disruption of KCNE1 modelling long QT syndrome 5. J Physiol 578 (2007) 99-114
49. Verrier R.L., Nearing B.D., La Rovere M.T., et al. Ambulatory electrocardiogram-based tracking of T wave alternans in postmyocardial infarction patients to assess risk of cardiac arrest or arrhythmic death. J Cardiovasc Electrophysiol 14 (2003) 705-711
50. Rashba E.J., Cooklin M., MacMurdy K., et al. Effects of selective autonomic blockade on T-wave alternans in humans. Circulation 105 (2002) 837-842
51. Klingenheben T., Gronefeld G., Li Y.G., and Hohnloser S.H. Effect of metoprolol and d,l-sotalol on microvolt-level T-wave alternans. Results of a prospective, double-blind, randomized study. J Am Coll Cardiol 38 (2001) 2013-2019
52. Zacks E.S., Morin D.P., Ageno S., et al. Effect of oral beta-blocker therapy on microvolt T-wave alternans and electrophysiology testing in patients with ischemic cardiomyopathy. Am Heart J 153 (2007) 392-397
53. Arking D.E., Pfeufer A., Post W., et al. A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet 38 (2006) 644-651